Case-based debate: is there evidence for local treatment in oligometastatic prostate cancer?
Treatment options for mucosal melanoma patients
A biosimilar’s developmental pathway: the final analysis of GP2013
Why uveal melanoma is a good candidate for vaccination and the importance of the abnormal ligandome
Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma